Dale Ross will leave his position as CEO of radiation therapy center operator US Oncology, effective February 1.
Ross, who has served as CEO since the Houston-based company's inception in 1992, will remain as executive chairman.
Company president Bruce D. Broussard will assume the title and duties of CEO on February 1. He joined US Oncology in August 2000 as chief financial officer (CFO) and was promoted to president in November 2005.
Related Reading
US Oncology posts mixed results in Q2, August 14, 2007
US Oncology postpones Q2 results, August 8, 2007
US Oncology shows Q4 revenue uptick, February 22, 2007
Elekta inks US Oncology deal, August 31, 2006
US Oncology, Molecular Profiling Institute form cancer venture, August 4, 2006
Copyright © 2008 AuntMinnie.com
